WuXi

WuXi Biologics provides an open-access, integrated technology platform for biologics drug development. We are the only true service platform in the world offering end-to-end solutions to empower anyone to discover, develop and manufacture biologics from concept to commercial manufacturing. Our single-source approach to biologics development saves our clients critical time and money. See below how our experience, capacities and quality make us a world leading (CDMO). ExperienceWuXi Biologics' leadership team consists of industry experts with 15-20 years of experience in biological drug development in the U. S./EU. While at WuXi this team has contributed to 1 BLA and 66 worldwide INDs in just 3 years! ExpertiseWuXi Biologics has over 170+ returnees from large pharma and small biotechs in the U. S./EU. These scientists cover all facets of drug development from discovery to manufacture of final drug product. Capacity and CapabilitiesWe have strong technical capabilities and an open-access technology platform that allows our customers to initiate a project at any stage in the development process. We have assembled one of the largest biologics development teams in the global biologics industry with 800+ scientists. We also operate one of the world's largest cell culture development laboratories with over 275 bioreactors with individual capacity ranging from 1 L to 200 L. In Q2 2017 we operate the world's largest disposable bioreactor-based biologics commercial manufacturing facilities with a planned manufacturing capacity of 30,000 L (14 x 2,000 L fed-batch production and 2 x 1,000 L perfusion-based cell culture productions systems). Quality & PerformanceWe provide a quality system and operations that meet worldwide regulatory standards. We have routinely and successfully passed over 60 quality audits by our clients, including 5 by EU Qualified Persons (QPs) and former U. S. FDA inspectors.